Literature DB >> 12464455

A role for electrotonic coupling in the striatum in the expression of dopamine receptor-mediated stereotypies.

Holly Moore1, Anthony A Grace.   

Abstract

Stimulation of dopamine (DA) receptors in the striatum evokes a number of alterations in motor behavior in rats, as well as causing several alterations in cellular physiology, including changes in membrane potential, cell excitability, afferent drive, and electrotonic coupling. One cellular property that is potently modulated by DA stimulation is electrotonic coupling, a process shown to subserve motor pattern generation. To examine whether electrotonic coupling plays a role in mediating a specific set of DA receptor-mediated motor behaviors, we tested the effects of two inhibitors of gap junction conductance, carbenoxolone (CARB) and anandamide (AEA), on apomorphine (APO)-induced motor responses. We then used intra-striatal infusions of CARB to determine the role of electrotonic coupling specifically in the ventral striatum in the expression of APO-induced behaviors. APO (2.5-3.0 mg/kg, i.p.) significantly increased motor activity (a composite score) and the frequencies of oral and sniffing stereotypies. APO also disrupted grooming initiation and completion. APO-induced oral stereotypies were selectively blocked by systemic administration of CARB (7.0, 35.0 mg/kg). Moreover, although CARB alone disrupted the initiation and completion of grooming sequences, it also partially normalized APO-induced disruptions in grooming. AEA (0.5, 1.5 mg/kg) also blocked APO-induced oral stereotypies at the higher dose, but differed from CARB in that it did not restore normal grooming behaviors but, instead, appeared to "release" locomotion. Bilateral infusion of carbenoxolone (50 pmol) into the ventral striatum also blocked the oral stereotypies induced by systemic APO. We conclude from these and previous experiments that gap junctions play an important role in normal motor behavior, and furthermore that disruption of motor behavior in the form of oral and sniffing stereotypies associated with systemic APO administration may be a consequence of this heightened electrotonic coupling in the striatum. These results may be relevant to diseases and pharmacotherapies associated with disruptions of motor and possibly cognitive sequencing.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12464455     DOI: 10.1016/S0893-133X(02)00383-4

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  14 in total

1.  The role of connexin-36 gap junctions in alcohol intoxication and consumption.

Authors:  Scott C Steffensen; Katie D Bradley; David M Hansen; Jeffrey D Wilcox; Rebecca S Wilcox; David W Allison; Collin B Merrill; Jeffrey G Edwards
Journal:  Synapse       Date:  2010-12-28       Impact factor: 2.562

2.  Modafinil potentiates cocaine self-administration by a dopamine-independent mechanism: possible involvement of gap junctions.

Authors:  Maddalena Mereu; Takato Hiranita; Chloe J Jordan; Lauren E Chun; Jessica P Lopez; Mark A Coggiano; Juliana C Quarterman; Guo-Hua Bi; Jacqueline D Keighron; Zheng-Xiong Xi; Amy Hauck Newman; Jonathan L Katz; Gianluigi Tanda
Journal:  Neuropsychopharmacology       Date:  2020-04-27       Impact factor: 7.853

3.  Analysis of carbenoxolone by ultra-high-performance liquid chromatography tandem mass spectrometry in mouse brain and blood after systemic administration.

Authors:  Justin L Poklis; Maciej M Gonek; Carl E Wolf; Hamid I Akbarali; William L Dewey
Journal:  Biomed Chromatogr       Date:  2019-01-07       Impact factor: 1.902

4.  Dopamine and serotonin metabolism in response to chronic administration of fluvoxamine and haloperidol combined treatment.

Authors:  Y Chertkow; O Weinreb; M B H Youdim; H Silver
Journal:  J Neural Transm (Vienna)       Date:  2007-06-18       Impact factor: 3.575

5.  Dopamine and cyclic-AMP regulated phosphoprotein-32-dependent modulation of prefrontal cortical input and intercellular coupling in mouse accumbens spiny and aspiny neurons.

Authors:  S-P Onn; M Lin; J-J Liu; A A Grace
Journal:  Neuroscience       Date:  2007-11-28       Impact factor: 3.590

6.  Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia.

Authors:  Stephanie M Perez; Li Chen; Daniel J Lodge
Journal:  Psychoneuroendocrinology       Date:  2014-05-14       Impact factor: 4.905

7.  A substrate trapping mutant form of striatal-enriched protein tyrosine phosphatase prevents amphetamine-induced stereotypies and long-term potentiation in the striatum.

Authors:  Roman Tashev; Paula J Moura; Deepa V Venkitaramani; Chiara Prosperetti; Diego Centonze; Surojit Paul; Paul J Lombroso
Journal:  Biol Psychiatry       Date:  2008-11-20       Impact factor: 13.382

8.  Carbenoxolone does not cross the blood brain barrier: an HPLC study.

Authors:  Yevgen Leshchenko; Sergei Likhodii; Wendy Yue; William M Burnham; Jose L Perez Velazquez
Journal:  BMC Neurosci       Date:  2006-01-11       Impact factor: 3.288

9.  Enteric short-chain fatty acids: microbial messengers of metabolism, mitochondria, and mind: implications in autism spectrum disorders.

Authors:  Derrick F MacFabe
Journal:  Microb Ecol Health Dis       Date:  2015-05-29

10.  Protective and therapeutic potency of N-acetyl-cysteine on propionic acid-induced biochemical autistic features in rats.

Authors:  Abeer M Aldbass; Ramesa Shafi Bhat; Afaf El-Ansary
Journal:  J Neuroinflammation       Date:  2013-03-27       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.